This message was sent to ##Email##
|
| June 27, 2018 |
| |  | | |
|
|
|
| |
Precision Vaccinations
Young women who received the HPV vaccine showed a lower degree of dysplasia, which may eventually lead to cervical cancer, reports a new study.
If a woman suffers from severe dysplasia, a tissue sample is taken. It can reveal precursor lesions to cervical cancer.
These researchers concluded ... the HPV vaccine works!
To be precise, the risk was reduced by 40 percent.
READ MORE
ASCT
After thirty-nine years, the ASCT is still committed to its role as the collective voice for cytotechnologists!
The field is constantly evolving, and the cytotechnologist's role is expanding at a more rapid pace than ever. We are integral members of the diagnostic team, and as such, it is important to bring our needs and ideas to the forefront of an ever-changing work environment. The ASCT remains focused on providing its members with significant resources to help you stay current on critical issues involving workload, proficiency testing, licensure, continuing education, and the workforce.
Your support as an active member is essential for the ASCT to remain the society that represents cytotechnologists. Your membership and involvement directly impact our ability to serve your personal needs, as well as the needs of our profession.
READ MORE
| Date |
Event |
Location |
More information |
July 2018 |
Milan System for Salivary Gland FNA
|
Your PC |
Esther Diana Rossi, MD, PhD, MIAC
Division of Anatomic Pathology and Histology
Catholic University “Agostino Gemelli” School of Medicine
Rome, Italy
Details
|
Available for 6 months after subscribing |
Quality Assessment Center (QAC) Cell Blocks Basics Workbench
|
Your PC |
Details |
Available for 6 months after subscribing |
Quality Assessment Center (QAC)
Document Control for Cytopathology Workbench
|
Your PC |
Details |
Available for 6 months after subscribing |
Quality Assessment Center (QAC)
The LEAN Cytopathology Laboratory Workbench
|
Your PC |
Details |
May 3 - 5, 2019 |
2019 ASCT Annual Conference
|
San Juan, Puerto Rico |
Details |
CAP Today
With core needle biopsies of the breast, if something looks like an epithelial malignancy, ask yourself: Is it really a carcinoma? If it is a carcinoma, ask yourself if it is a primary breast carcinoma.
That and more — “re-review triple-negative cancers,” for example — was the advice of Laura C. Collins, MD, in a CAP17 session on ancillary testing in breast pathology, presented with Stuart J. Schnitt, MD.
READ MORE
Healio
The FDA granted priority review to a supplemental biologics license application that seeks approval of the HPV 9-valent vaccine, recombinant, for use among women and men aged 27 to 45 years for the prevention of HPV-related cancers. The FDA set an action date of Oct. 6.
READ MORE
MedPage Today
Patients with locally advanced cervical cancer had significantly increased disease-free survival (DFS) when treated with chemoradiation instead of neoadjuvant chemotherapy followed by radical surgery, a large randomized trial published in the Journal of Clinical Oncology showed. The chemoradiation group had a median DFS rate of 76.7% compared with 69.3% for the patients assigned to neoadjuvant chemotherapy and surgery. Overall survival did not differ between treatment groups.
READ MORE
CAP Today
Surgical pathologists take their tumor nomenclature from the WHO Classification of Tumours, but cytopathologists take their terminology from where the consensus groups convened — Bethesda, Paris, Milan and Yokohama — to formulate terminology recommendations. The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) is now in its second edition.
READ MORE
Medical News Today
Vitamin D is hailed as a wonder nutrient, capable of lowering a person's risk of different forms of cancer. Recent research now confirms that people with high enough levels of this vitamin in their blood have a significantly lower risk of breast cancer.
READ MORE
Newswise
The incidence of anal cancer continues to rise. Despite making the headlines with Farrah Fawcett, people are still reluctant to discuss this important cancer. The majority of patients with this cancer are cured by a combination of treatment of radiation and chemotherapy. However, this treatment can have significant side effects, particularly in the elderly or those in poor general health.
READ MORE
HealthDay News
Children with neuroblastoma, a pediatric cancer of nerve cells, are vulnerable to mental health and behavioral problems, a new study finds.
Neuroblastoma is diagnosed at a median age of 17.3 months. Treatment advances have prolonged survival for many patients, the study authors said.
READ MORE
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
